Complement in the pathogenesis of Alzheimer's disease
1Systems Immunity Research Institute and Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK. morganbp@cardiff.ac.uk.
The complement system, crucial for immunity, surprisingly impacts brain development and neurological diseases like Alzheimer's. Understanding its role is key to exploring potential brain therapies.
Area of Science:
- Neuroscience
- Immunology
- Complement System Biology
Background:
- The complement system, primarily known for immune defense, has emerged as a significant factor in normal brain development and pathological processes.
- Its unexpected roles in the central nervous system necessitate a re-evaluation of its functions in both health and disease.
Purpose of the Study:
- To review the current understanding of complement's function in the healthy brain.
- To explore the influence of complement on the development and progression of Alzheimer's disease pathology.
- To discuss the challenges and potential drawbacks of targeting the complement system therapeutically in the context of Alzheimer's disease.
Main Methods:
- Literature review focusing on complement's role in neuroscience.
- Analysis of existing research on complement involvement in neurological disorders, particularly Alzheimer's disease.
- Discussion of therapeutic strategies and their potential implications.
Main Results:
- The complement system plays a role in normal brain development, though many aspects remain poorly understood.
- Complement activation is implicated in exacerbating inflammation and pathology in various neurological and neuropsychiatric diseases, including Alzheimer's disease.
- Evidence suggests complement contributes to the genesis and progression of Alzheimer's pathology.
Conclusions:
- The complement system's involvement in the brain highlights a significant gap in our understanding of neurobiology and neuroinflammation.
- Targeting the complement system for Alzheimer's disease treatment presents complex challenges and potential risks that require careful consideration.
- Further research is needed to elucidate the precise mechanisms of complement action in the brain and to develop safe and effective therapeutic interventions.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Complement System
Alzheimer's Disease: Treatment
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
